Brief: Janux Therapeutics Posts Q3 Loss Per Share Of $0.26
Nov 9 (Reuters) - Janux Therapeutics Inc JANX.O :
* JANUX THERAPEUTICS REPORTS BUSINESS HIGHLIGHTS AND THIRD
QUARTER
2021 FINANCIAL RESULTS
* JANUX THERAPEUTICS INC- QTRLY LOSS PER SHARE $0.26
Source text for Eikon: ID:nBw1NmG6Da
Further company coverage: JANX.O
((Reuters.Briefs@thomsonreuters.com;))